OncoGenex Pharmaceuticals, Inc. (OGXI) Tops Q3 EPS by 9c

November 8, 2012 4:55 PM EST
Get Alerts OGXI Hot Sheet
Trade OGXI Now!
Join SI Premium – FREE
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) reported Q3 EPS of ($0.40), $0.09 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $6.57 million versus the consensus estimate of $4.52 million.

For earnings history and earnings-related data on OncoGenex Pharmaceuticals, Inc. (OGXI) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment